Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study. J of Skin. 2022;6(6):s102. doi:10.25251/skin.6.supp.102